COLLPLANT BIOTECH. IS-01 (CPT) — Net Asset Momentum

Latest YoY growth as of December 2025: -54.8%

COLLPLANT BIOTECH. IS-01 (CPT) recorded a net asset momentum of -54.8% as of December 2025, with net assets of €6.08 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check COLLPLANT BIOTECH. IS-01 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

YoY Momentum

-54.8%
Year-over-year

Current Net Assets

€6.08 Million
EUR · December 2025

Years of Data

5
2021 – 2025

Country

Germany
F

COLLPLANT BIOTECH. IS-01 Net Asset Momentum (2021–2025)

This chart tracks COLLPLANT BIOTECH. IS-01's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -54.8%, with net assets of €6.08 Million EUR as of December 2025. Read COLLPLANT BIOTECH. IS-01 debt and liabilities for a breakdown of total debt and financial obligations.

Annual Net Asset History for COLLPLANT BIOTECH. IS-01 (2021–2025)

The table below shows the complete annual net asset history for COLLPLANT BIOTECH. IS-01 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see CPT market cap overview.

Year Net Assets (EUR) Total Assets Total Liabilities YoY Momentum
2025 €6.08 Million €10.79 Million €4.70 Million ▼ -54.8%
2024 €13.46 Million €18.71 Million €5.25 Million ▼ -52.5%
2023 €28.34 Million €34.13 Million €5.79 Million ▼ -12.2%
2022 €32.28 Million €37.77 Million €5.49 Million ▼ -28.5%
2021 €45.12 Million €51.22 Million €6.10 Million